YBX1, Targeted By Microrna-382-5p, Promotes Laryngeal Squamous Cell Carcinoma Progression < em > via < /em > Modulating RAS/MAPK Signaling

CONCLUSION: Together, our results indicated that YBX1 is an important promoter of LSCC progression. And miR-382-5p/YBX1/RAS/MAPK signaling pathway can be perceived as a promising target in the treatment of LSCC.PMID:38214357 | DOI:10.2174/1574892818666230207091720

Source: Recent Patents on Anti-Cancer Drug Discovery - January 12, 2024 Category: Cancer & Oncology Authors: Wen Zeng Yiyun Pan Hailong Chen Xianhua Lei Xiangmin Zhang Source Type: research